Modulation of cyclic nucleotide phosphodiesterase by dietary fats in rat heart

Feeding oils of different fatty acid composition modifies the fatty acid composition of cardiac membrane phospholipids, thereby inducing changes in cardiac contractility and altering response of adenylate cyclase to catecholamines. In the present study, the effect of such dietary manipulations on cyclic nucleotide phosphodiesterase, which is involved in the control of cyclic nucleotide intracellular levels and in the control of cardiac contractility, was investigated. Rats were fed either a saturated fatty acid-enriched diet (8 weight percent [%] coconut oil +2% sunflower oil), an n−6 fatty acid-enriched diet (10% sunflower oil) or an n−3 fatty acid-enriched diet (8% fish oil +2% sunflower oil). The fatty acid composition of cardiac phospholipids, as well as the nonesterified fatty acid content of heart were markedly altered by the diets. The 18∶2n−6 and 20∶4n−6 content of cardiac phospholipids was markedly (−49%) depressed by fish oil as compared with sunflower oil feeding, but the nonesterified fatty acid level of heart membrane was lowest in coconut oil-fed rats. In addition, fish oil feeding more drastically depressed the n−6/n−3 fatty acid ratio in the nonesterified fatty acid pool than in cardiac phospholipids. Cyclic AMP phosphodiesterase activity was the lowest in both the particulate and soluble fractions of heart from rats fed sunflower oil, whereas cyclic GMP phosphodiesterase activity was not altered by the diets. Cyclic AMP phosphodiesterase activity was decreased by 18 and 12% in heart membranes of the sunflower oil group as compared to that of the coconut oil and fish oil groups, respectively. In heart cytosol, the activity decreased by 30% when compared with the activity of the coconut oil group. Additionalin vitro experiments showed that polyunsaturated fatty acids were more potent inhibitors of cyclic AMP phosphodiesterase than saturated fatty acids. These results suggest that polyunsaturated fatty acid-enriched diets might decrease heart cyclic AMP phosphodiesterase activity by increasing non-esterified polyunsaturated fatty acids, especially those of the n−6 series, but more complex and indirect mechanisms are very likely to be involved.